Literature DB >> 25918798

Anti-proliferation effect on human breast cancer cells via inhibition of pRb phosphorylation by taiwanin E isolated from Eleutherococcus trifoliatus.

Hui-Chun Wang, Yen-Hsueh Tseng, Hui-Rong Wu, Fang-Hua Chu, Yueh-Hsiung Kuo, Sheng-Yang Wang.   

Abstract

Eleutherococcus trifoliatus has been used as a folk medicine since ancient times, especially as refreshing qi medicines. In our current study, taiwanin E, which possesses strong cytotoxicity, was isolated from the branches of E. trifoliatus by using a bioactivity guided fractionation procedure. Taiwanin E presented a potent anti-proliferation activity on the growth of a human breast adenocarcinoma cell line (MCF-7), with an IC50 value for cytotoxicity of 1.47 μM. Cell cycle analysis revealed that the proportion of cells in the G0/G1 phase increased in a dose-dependent manner (from 79.4% to 90.2%) after 48 h exposure to taiwanin E at a dosage range from 0.5 to 4μM. After treatment with taiwanin E, phosphorylation of retinoblastoma protein (pRb) in MCF-7 cells was inhibited, accompanied by a decrease in the levels of cyclin D1, cyclin D3 and cyclin-dependent kinase 4 (cdk4) and cdk6; in addition, there was an increase in the expression of cyclin-dependent kinase inhibitors p21(WAF-1/Cip) and p27(Kip1). The results suggest that taiwanin E inhibits cell cycle progression of MCF-7 at the G0/G1 transition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25918798

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  5 in total

Review 1.  The role of the gut microbiota in multiple sclerosis.

Authors:  Jorge Correale; Reinhard Hohlfeld; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2022-08-05       Impact factor: 44.711

Review 2.  Can Aidi injection alleviate the toxicity and improve the clinical efficacy of radiotherapy in lung cancer?: A meta-analysis of 16 randomized controlled trials following the PRISMA guidelines.

Authors:  Zheng Xiao; Rui Liang; Cheng-Qiong Wang; Shaofeng Xu; Nana Li; Yuejuan He; Fushan Tang; Ling Chen; Hu Ma
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

3.  Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines.

Authors:  Zheng Xiao; Chengqiong Wang; Yongping Sun; Nana Li; Jing Li; Ling Chen; Xingsheng Yao; Jie Ding; Hu Ma
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

4.  Has aidi injection the attenuation and synergistic efficacy to gemcitabine and cisplatin in non-small cell lung cancer? A meta-analysis of 36 randomized controlled trials.

Authors:  Zheng Xiao; Chengqiong Wang; Ling Chen; Xuemei Tang; Lianhong Li; Nana Li; Jing Li; Qihai Gong; Fushan Tang; Jihong Feng; Xiaofei Li
Journal:  Oncotarget       Date:  2017-01-03

5.  Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel-Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis of 36 Randomized Controlled Trials.

Authors:  Zheng Xiao; Chengqiong Wang; Lianhong Li; Xuemei Tang; Nana Li; Jing Li; Ling Chen; Qihai Gong; Fushan Tang; Jihong Feng; Xiaofei Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-11       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.